Randomized Study on the Efficacy of Standard Versus Low Roxadustat Dose for Anemia in Patients on Peritoneal Dialysis

INTRODUCTION: We aimed to investigate whether a lower starting dose of roxadustat (∼1–1.4 mg/kg) converted from erythropoiesis-stimulating agent (ESA) could achieve a comparable hemoglobin (Hb) target (≥100 and ≤120 g/l) compared with the standard weight-based dose (∼1.5–2 mg/kg) at week 12 through...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhikai, Ma, Tiantian, Xu, Xiao, Fu, Gang, Zhao, Jing, Xu, Ying, Yang, Bin, Song, Di, Zhu, Sainan, Lv, Jicheng, Dong, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897289/
https://www.ncbi.nlm.nih.gov/pubmed/35257058
http://dx.doi.org/10.1016/j.ekir.2021.12.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897289/
https://www.ncbi.nlm.nih.gov/pubmed/35257058
http://dx.doi.org/10.1016/j.ekir.2021.12.025

Ejemplares similares